ABSTRACT
Transcranial Magnetic Stimulation (TMS) involves pulsed magnetic fields that pass through the scalp to stimulate the brain, with incidental stimulation to superficial nerves and muscles. From a research perspective, the tactile sensations can be a problematic confound, particularly when stimulation approaches an unpleasant or painful level. Additionally, tactile sensations contribute to difficult challenges in establishing an appropriate sham control condition. Clinically, some patients find stimulation uncomfortable or intolerable. Clinicians need data on adjustments to stimulation parameters to improve tolerability and efficacy. The primary objective of this study was to characterize the tolerability of TMS by location (over modified Beam F3 prefrontal, THREE-D prefrontal, right orbitofrontal, medial prefrontal, motor, and parietal cortical targets, as well as the knee) and by frequency (1 Hz, 10 Hz, or iTBS), with increasing levels of stimulation intensity. We also characterized sensory thresholds and qualitative aspects of stimulation across locations and frequencies. For location, sites distal to the facial nerves and muscle (Knee, P3, M1, mPFC) were more tolerable, followed by Beam F3, with the THREE-D and AF8 locations as least tolerable. For frequency, we found that 1 Hz was significantly more tolerable than 10 Hz and iTBS. iTBS was more annoying than 10 Hz but only marginally different in tolerability. TMS researchers and clinicians should understand the impact of sensation based on location and frequency, with increasing stimulation intensity. This is a single-session study in generally healthy individuals, and there is a need for additional data to further inform research and clinical practice.
Competing Interest Statement
Neketa Nesmith: None Megan Senda: None Yang Hou: None Kirthin Dev: None Austin M. Spitz: None F. Andrew Kozel: Supported by Mina Jo Powell Endowed Chair - Neurological Sciences. Travel and small honorarium for Clinical TMS Society meeting lectures 2021 & 2022 and as Associate Editor of Transcranial Magnetic Stimulation. Past temporary loan of equipment from Neuronetics and NIRx. Kevin A. Johnson: Former employee of Neuronetics with no current financial ties. Past temporary loan of equipment from Neuronetics and NIRx.
Clinical Trial
NCT06354686
Funding Statement
This research was not supported by any specific grant funding from agencies in the public, commercial, or non-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Participants first provided informed consent, as approved by the Florida State University Institutional Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study may be available upon reasonable request to the authors.
